Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

JDOC vs. HRTS: which is better?

Bottom line

JDOC vs HRTS: the short answer

JDOC (JPMorgan Healthcare Leaders ETF) and HRTS (Tema Heart & Health ETF) share a meaningful slice of their top holdings — about 56% by weight.

JDOC is cheaper at 0.65% vs 0.75% — a difference of $10 a year per $10,000 invested.

Over one year, HRTS returned +23.6% vs +14.9% for JDOC.

Updated Nov 19, 2026

JDOC vs HRTS side by side

JDOCHRTS
TypeETFETF
Fund familyJ.P. MorganInnovator
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.65%0.75%
Annual cost per $10k$65$75
10-yr cost on $10k (prospectus)$810$1,168
Max front loadNoneNone
12b-1 fee—0%
1-yr return+14.9%+23.6%
5-yr return (annualized)——
10-yr return (annualized)——
Best quarter+11.3%+15.8%
Worst quarter−11.9%−12.4%
Net assets (fund)$9.1M$51.9M
Number of holdings6145
Portfolio turnover92%4%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearJDOCHRTSDifference
2025+14.9%+23.6%−8.7%
2024−0.6%+3.6%−4.2%

Source: Fund prospectus bar charts

Holdings overlap

14 of JDOC's top 25 holdings also appear in HRTS's top 25.

Shared top holdings
HoldingJDOCHRTS
AbbVie, Inc.7.85%2.40%
Eli Lilly & Co.7.76%11.52%
UnitedHealth Group, Inc.5.85%5.24%
Merck & Co., Inc.4.82%4.27%
Johnson & Johnson4.82%3.59%
AstraZeneca plc3.76%4.00%
Thermo Fisher Scientific, Inc.3.73%3.97%
Bristol-Myers Squibb Co.3.57%2.09%
Abbott Laboratories3.11%2.61%
Novo Nordisk A/S2.61%5.24%
Danaher Corp.2.16%2.66%
Edwards Lifesciences Corp.1.73%1.75%
Regeneron Pharmaceuticals, Inc.1.60%1.67%
Novartis AG1.60%3.38%

Source: SEC Form N-PORT

JDOC top 10

  1. AbbVie, Inc. — 7.85%
  2. Eli Lilly & Co. — 7.76%
  3. UnitedHealth Group, Inc. — 5.85%
  4. Merck & Co., Inc. — 4.82%
  5. Johnson & Johnson — 4.82%
  6. AstraZeneca plc — 3.76%
  7. Thermo Fisher Scientific, Inc. — 3.73%
  8. Bristol-Myers Squibb Co. — 3.57%
  9. Abbott Laboratories — 3.11%
  10. CVS Health Corp. — 2.83%

HRTS top 10

  1. Eli Lilly & Co — 11.52%
  2. UnitedHealth Group Inc — 5.24%
  3. Novo Nordisk A/S — 5.24%
  4. Roche Holding AG — 4.50%
  5. Merck & Co Inc — 4.27%
  6. AstraZeneca PLC — 4.00%
  7. Thermo Fisher Scientific Inc — 3.97%
  8. Johnson & Johnson — 3.59%
  9. Gilead Sciences Inc — 3.43%
  10. Novartis AG — 3.38%

FAQ

What is the difference between JDOC and HRTS?
JDOC (JPMorgan Healthcare Leaders ETF) and HRTS (Tema Heart & Health ETF) share a meaningful slice of their top holdings — about 56% by weight. JDOC is cheaper at 0.65% vs 0.75% — a difference of $10 a year per $10,000 invested.
Which is cheaper, JDOC or HRTS?
JDOC has the lower expense ratio (0.65%).
Should I own both JDOC and HRTS?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.